cost‑effectiveness
7 Tactics to Stop Overpaying on Chronic Disease Management
In 2024, pay-for-performance studies showed biologic drug regimens cut total annual drug spend by 18% versus conventional therapies, proving that switching to value-based biologics is the quickest way to stop overpaying on chronic disease management. This shift also lifts patient disease-control scores, creating a win-win for payers and providers. Medical